Curi Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,805
Closed -$6.8M 139
2023
Q4
$6.8M Sell
12,805
-1,668
-12% -$807K 0.94% 35
2023
Q3
$7.33M Sell
14,473
-437
-3% -$233K 1.12% 33
2023
Q2
$7.78M Sell
14,910
-1,083
-7% -$584K 1.05% 34
2023
Q1
$9.22M Sell
15,993
-4,385
-22% -$2.47M 1.33% 28
2022
Q4
$11.2M Sell
20,378
-540
-3% -$286K 1.57% 23
2022
Q3
$10.6M Buy
20,918
+818
+4% +$458K 1.76% 21
2022
Q2
$10.9M Buy
20,100
+25
+0.1% +$13.8K 2.1% 17
2022
Q1
$11.9M Buy
20,075
+97
+0.5% +$55.7K 2.05% 18
2021
Q4
$13.3M Buy
+19,978
New +$12.5M 2.3% 17
2021
Q1
Sell
-17
Closed -$7K 445
2020
Q4
$7K Buy
+17
New +$7.97K 0.01% 290

Other funds holding TMO

Curi Wealth Management's TMO Position: Q1 2024 in Review

Curi Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 12,805 shares — an estimated $6.8M sold.

Curi Wealth Management first reported a position in TMO in Q4 2020 and held it in 10 quarters. The position peaked at $13.3M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Curi Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Curi Wealth Management sold 12,805 Thermo Fisher Scientific shares in Q1 2024, an estimated $6.8M.
  • Curi Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 10 quarters.
  • Curi Wealth Management's Thermo Fisher Scientific position peaked at $13.3M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Curi Wealth Management's 13F filing for Q1 2024.